GIORGIONI, Gianfabio
 Distribuzione geografica
Continente #
NA - Nord America 11.755
EU - Europa 5.002
AS - Asia 4.355
SA - Sud America 496
Continente sconosciuto - Info sul continente non disponibili 273
AF - Africa 190
OC - Oceania 29
Totale 22.100
Nazione #
US - Stati Uniti d'America 11.354
CN - Cina 1.715
SG - Singapore 1.306
RU - Federazione Russa 1.199
IT - Italia 1.089
DE - Germania 662
BR - Brasile 408
VN - Vietnam 377
HK - Hong Kong 342
GB - Regno Unito 332
CA - Canada 319
SE - Svezia 301
UA - Ucraina 293
PL - Polonia 268
FR - Francia 259
FI - Finlandia 237
ZA - Sudafrica 140
KR - Corea 118
TR - Turchia 118
IE - Irlanda 85
BD - Bangladesh 81
IN - India 71
NL - Olanda 57
JP - Giappone 55
CZ - Repubblica Ceca 53
MX - Messico 47
BE - Belgio 44
ES - Italia 35
AR - Argentina 26
AU - Australia 26
IQ - Iraq 23
PK - Pakistan 21
UZ - Uzbekistan 17
EG - Egitto 15
HR - Croazia 14
IR - Iran 14
PE - Perù 14
AT - Austria 13
EC - Ecuador 13
EU - Europa 13
AE - Emirati Arabi Uniti 10
CH - Svizzera 10
ID - Indonesia 10
LT - Lituania 10
SA - Arabia Saudita 10
CO - Colombia 9
MA - Marocco 9
MY - Malesia 9
AZ - Azerbaigian 8
UY - Uruguay 8
KE - Kenya 7
PT - Portogallo 7
VE - Venezuela 7
CR - Costa Rica 6
KG - Kirghizistan 6
TH - Thailandia 6
DZ - Algeria 5
GR - Grecia 5
GT - Guatemala 5
HN - Honduras 5
JO - Giordania 5
NP - Nepal 5
RO - Romania 5
TN - Tunisia 5
BB - Barbados 4
BY - Bielorussia 4
CL - Cile 4
PY - Paraguay 4
SY - Repubblica araba siriana 4
BG - Bulgaria 3
GE - Georgia 3
HU - Ungheria 3
IL - Israele 3
PA - Panama 3
PH - Filippine 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
AL - Albania 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
EE - Estonia 1
GA - Gabon 1
GD - Grenada 1
GH - Ghana 1
GY - Guiana 1
LB - Libano 1
LK - Sri Lanka 1
Totale 21.825
Città #
Ashburn 1.073
Fairfield 768
Woodbridge 756
Singapore 706
Jacksonville 705
San Jose 611
Chandler 534
Dallas 487
Houston 469
Ann Arbor 446
Council Bluffs 422
Wilmington 376
Boardman 334
Hong Kong 334
Seattle 328
Cambridge 287
Los Angeles 275
Beijing 271
Nanjing 234
New York 203
Camerino 202
Toronto 184
Warsaw 170
Johannesburg 127
Ho Chi Minh City 123
San Mateo 121
Helsinki 119
Seoul 113
The Dalles 108
Tongling 108
Dearborn 106
Lawrence 100
Princeton 100
Munich 95
Lauterbourg 92
Kraków 91
Istanbul 89
Orem 89
Columbus 86
Santa Clara 86
Dublin 83
Nanchang 82
Ogden 82
Moscow 80
Buffalo 79
Hanoi 75
London 71
Shenyang 69
Lachine 63
Denver 59
Shanghai 59
Düsseldorf 58
Kunming 56
Milan 55
Chicago 54
Phoenix 52
San Francisco 52
Redwood City 51
Tokyo 49
Frankfurt am Main 44
Tianjin 43
Brooklyn 42
Hebei 42
Brussels 40
Brno 38
Atlanta 37
Rome 35
Guangzhou 33
Montreal 32
São Paulo 31
Jiaxing 30
San Diego 30
Trieste 28
Wuhan 28
Changsha 27
Turku 27
Boston 26
Philadelphia 26
Stockholm 26
Augusta 25
Jinan 25
St Louis 25
Bremen 24
Chennai 24
Hangzhou 23
Poplar 23
Ascoli Piceno 22
Centro 22
Da Nang 22
Leawood 21
Ningbo 20
Venezia 19
Zhengzhou 19
Hefei 18
Redondo Beach 17
Venice 17
Auburn Hills 16
Haiphong 16
Nuremberg 16
Rio de Janeiro 16
Totale 14.252
Nome #
Quaternary ammonium surfactants derived from leucine and methionine: Novel challenging surface active molecules with antimicrobial activity 961
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 634
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 336
1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor 332
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 330
5HT2B receptor antagonists: a probe for spotting the pharmacophore 314
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 303
4-(4-Fluorobenzoyl)-1-[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]piperidine and its derivatives: synthesis and affinity at 5-HT2A, 5-HT2B and 5-HT2c serotonin receptors 279
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 273
Novel antitumor copper(ii) complexes designed to act through synergistic mechanisms of action, due to the presence of an NMDA receptor ligand and copper in the same chemical entity 268
Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane 263
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 253
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 246
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 244
14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry 243
Benzimidazole, benzoxazole and benzothiazole derivatives as 5HT(2B) receptor ligands. Synthesis and preliminary pharmacological evaluation 238
3-[2-[4-(4-Fluorobenzoyl)piperidin-1-yl]ethyl]-5,6,7,8-tetrahydro-4(3H)quinazolinones: serotonin 5-HT2A receptor antagonists endowed with potent, central action 238
Evaluation of P(L)LA-PEG-P(L)LA as processing aid for biodegradable particles from gas saturated solutions (PGSS) process 232
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 229
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 226
Evaluation of methoxy polyethylene glycol-polylactide diblock copolymers as additive in hypromellose film coating 225
Dimeric L-Dopa Derivatives as Potential Prodrugs 224
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 223
Synthesis and Evaluation of 2-(5-Methoxythiophen-3- yl)ethylamines as Potential Dopamine Agonists 222
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 221
Synthesis and pharmacological evaluation of 4-phenoxy-1,2,3,4-tetrahydroisoquinolines and 4,5,6,6a-tetrahydrochromeno [2,3,4-de]isoquinolines 219
Simplified analogues of Ritanserin and their affinity at 5-HT2A, 5-HT2B and 5-HT2C serotonin receptors 218
Monitoring the aggregation behaviour of self-assembling polymers through high-resolution ultrasonic spectroscopy, 218
Synthesis of Novel 4-Aryl-1,2,3,4-tetrahydroisoquinolines as Probes for Dopamine Receptor Ligands 218
4-(3-Piridil)-1,2,3,4-tetraidroisochinoline potenziali ligandi dei recettori della dopamina 216
New Flurbiprofen Derivatives: Synthesis, Membrane Affinity and Evaluation of in Vitro Effect on β-Amyloid Levels 216
New 2- pyridylethylamines with dopaminergic activity: synthesis and radioligand binding evaluation 216
Synthesis and Preliminary Pharmacological Evaluation of 5-Hydroxy- and 5,6-Dihydroxy-1,2,3,7,12,12a-hexahydrobenzo [5,6]cyclohepta[1,2,3-ij]isoquinoline Derivatives as Dopamine Receptor Ligands 215
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 215
Dopamine D-5 receptors: A challenge to medicinal chemists 212
Design, Synthesis and Biological Evaluation of Novel Chemical Entities as Potential Anticancer Drugs and for the Control of the Metastatic Process 211
Novel Imidazoline Compounds as Partial or Full Agonists of D2-Like Dopamine Receptors Inspired by I2-Imidazoline Binding Sites Ligand 2-BFI 211
Evaluation of polymer mucoadhesiveness by the use of acoustic spectroscopy 211
Synthesis and Pharmacological Characterization of 2-(4-Chloro-3-hydroxyphenyl)ethylamine and N,N-dialkyl Derivatives as Dopamine Receptor Ligands 210
16th Camerino-Noordwijkerhout Symposium - An Overview of Receptor Chemistry 208
Synthesis of L-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2,5-diketomorpholine as potential prodrug of L-Dopa 207
Chemical manipulations on the 1,4-dioxane ring of 5-HT1A receptor agonists lead to antagonists endowed with antitumor activity in prostate cancer cells 207
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders 205
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 204
Thermosensitive self-assembling block copolymers as drug delivery systems 203
New Systems for the Specific Delivery and Sustained Release of Dopamine to the Brain 201
4WD to Travel Inside the 5-HT1A Receptor World 201
Synthesis and cytotoxic activity evaluation of new Cu(I) complexes of bis(pyrazol-1-yl) acetate ligands functionalized with an NMDA receptor antagonist 200
Novel Dopamine Receptor Ligands Bearing Imidazoline Nucleus. 199
Evaluation of 2,3,4,8,13a hexahydro-1H-benzo[5,6]cyclohepta-6,7-dihydroxy[1,2,3-ef][3]benzazepine derivatives as dopamine receptor ligands 195
New L-dopa codrugs as potential antiparkinson agents 195
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 191
Glycosyl and polyalcoholic prodrugs of lonidamine. 190
Correlation among chemical structure, surface properties and cytotoxicity of N-acyl alanine and serine surfactants 189
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 188
trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: Synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D-1 receptor full agonist 187
Activity of N-(2-Phenylethyl)-N-n-Propyl-2-(3-Hydroxyphenyl)ethylamine Derivatives as Dopamine Receptor Ligands 184
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 184
Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments 184
Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats 183
Chemical–physical properties and cytotoxicity of N-decanoyl amino acid-based surfactants: Effect of polar heads 182
Synthesis, resolution and preliminary evaluation of trans-2-amino-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes and related derivatives as dopamine receptor ligands 182
Quaternary Ammonium Leucine-Based Surfactants: The Effect of a Benzyl Group on Physicochemical Properties and Antimicrobial Activity 182
Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior 180
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor 179
A Comparative Behavioural Analysis in Rats of the D2 Agonist RU 24213 and Two New Structurally Similar Compounds 176
DISCOVERY OF NEW POTENTIAL gamma-SECRETASE MODULATORS FOR THE TREATMENT OF ALZHEIMER’S DISEASE 176
Design, synthesis and preliminary pharmacological evaluation of new imidazolinonesas L-DOPA prodrugs 176
4-Aryloxy-1,2,3,4-tetrahydroisoquinolines as new potential antipsychotic drugs 175
Synthesis and Biological Evaluation of GABA Derivatives Able to Cross the Blood -Brain Barrier in Rats 174
Receptors in aging diseases: Dopamine receptors 172
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands 170
Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3,12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinoles as dopamine receptor ligands 170
Synthesis and Evaluation of N-n-Propyl-N-(2-phenylethyl)-2-(3-fluoro-4- hydroxyphenyl)ethylamine Derivatives as Dopamine Receptor Ligands 161
A de novo design probe of a dopamine receptor ligand based on a theoretical approach 160
Polyhydroxylic Prodrugs of Lonidamine 159
Imidazolidinoni profarmaci della L-DOPA 159
Synthesis and SAR of group 11 N-heterocyclic carbene complexes 159
Toxicological profiles and surface properties at physiological pH of N-decanoyl amino acids 152
Preparation and Pharmacological Characterization of trans-2-Amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like Dopamine Receptor Agonists 150
Structure-Activity Relationships of N-n-Propyl-2-(4-fluoro-3-hydroxyphenyl)ethylamine Derivatives as Dopamine Receptor Ligands 147
Synthesis and Dopamine Receptor Binding of 4-(2-Aminoethyl)-1H-pyrazole and Its N,N- Dialkyl Derivatives 143
Synthesis and dopamine receptor affinities of 6-amino-5,6,7,8-tetrahydroquinoline derivatives 142
L-Dopa codrugs containing antioxidant molecules as potential antiparkinson agents 140
Novel antitumor Cu(I) and Cu(II) complexes based on bioconjugate ligands rationally designed to act through synergistic mechanisms 140
New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma 139
Highly Potent and Selective Dopamine D4 Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma 135
Choline pivaloyl esters improve in rats cognitive and memory performances impaired by scopolamine treatment or cognitive and memory performances impaired by scopolamine treatment orlesions of the nucleus basalis of Meynert 134
Copper complexes with adamantane ring-conjugated ligands as promising agents for the treatment of glioblastoma 133
Novel Potent and Selective Dopamine D4 Receptor Piperidine Antagonists as Potential Alternatives for the Treatment of Glioblastoma 131
New anticancer copper complexes containing ligands conjugated with biologically active molecules 130
Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma 129
Investigating the role of the central melanocortin system in stress and stress-related disorders 129
Receptors in aging disease 129
ANTIDEPRESSANT-LIKE ACTIVITY OF NOVEL IMIDAZOLINE LIGANDS DIRECTED TO THE SEROTONIN 5-HT1A RECEPTOR 127
Copper Complexes with Adamantane Ring- Conjugated Ligands as Promising Agents for the Treatment of Glioblastoma 126
Effect on binge eating episode in female rats of a potent 1 antagonist analogue of spipethiane 125
IBUPROFEN AND LIPOIC ACID DIAMIDE AS CO-DRUGS WITH NEUROPROTECTIVE ACTIVITY: PHARMACOLOGICAL PROPERTIES AND EFFECTS IN Βeta-AMYLOID (1-40) INFUSED ALZHEIMER’S DISEASE RAT MODEL 120
Medicinal chemistry and pharmacology of purinergic receptors 120
Trends in drug Research 113
Totale 20.694
Categoria #
all - tutte 84.633
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.633


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022707 0 0 18 51 84 57 35 73 86 117 56 130
2022/20231.484 180 49 75 194 163 201 17 90 264 79 122 50
2023/20241.084 127 61 100 34 39 93 57 36 118 35 24 360
2024/20253.739 167 88 318 165 85 203 453 901 289 237 243 590
2025/20266.549 343 343 693 837 560 423 897 419 333 365 1.110 226
2026/2027602 324 175 103 0 0 0 0 0 0 0 0 0
Totale 22.100